Bookmark this page

View Printer Friendly PDF Printer Friendly PDF

Facts About...

MENINGOCOCCAL C CONJUGATE VACCINE
(e.g., Menjugate®)


What is it?

  • Meningococcal C conjugate (Men-C-C) vaccine protects against the C strain of the bacteria that causes invasive meningococcal disease (IMD). IMD can cause swelling of the lining of the brain and spinal cord (meningitis) and/or a blood infection. IMD can lead to serious illness or in some cases death. For more information, see Facts About... Meningitis.
  • Menjugate® and NeisVac-C® are Men-C-C vaccines that are approved for use in Canada.
  • Menjugate® is currently offered at Durham Region Health Department clinics.
  • Men-C-C vaccines do not protect against other strains of meningococcal bacteria (A, B, Y and W135). There are other vaccines available in Canada to protect against these strains. Talk to your health care provider for more information.

Who should receive the vaccine?

Men-C-C vaccine is part of the routine infant immunization schedule (given on or after the first birthday) and is publicly funded (free) for people who have not been immunized.

Under the Child Care and Early Years Act, 2014, one dose of Men-C-C vaccine is required for children attending child care in Ontario unless they have a valid exemption*.

Under the Immunization of School Pupils Act, one dose of Men-C-C vaccine is required for children who are less than 12 years of age and attending school in Ontario unless they have a valid exemption*.

Are there side effects with the vaccine?

The most common reported side effects are:

  • Redness, pain and swelling where the needle was given
  • Headache
  • Fussiness in children
  • Fatigue

Side effects are usually mild and last only a short time. A cold, wet compress applied to the injection site and/or acetaminophen can be used to help relieve pain, swelling, and/or mild fever after vaccination.

Severe allergic reactions after vaccination are very rare and may not be related to the vaccine. However, if you think a serious reaction is developing, seek medical attention right away. Any unusual or significant changes in your health or your child’s health after the immunization should be reported to a health care provider and the Health Department.

Who should NOT get the vaccine?

  • People who have been given the Menomune® (meningococcal polysaccharide) vaccine within the past 24 weeks.
  • People who have received a meningococcal conjugate vaccine within the past 4 weeks.
  • If you have any medical conditions, discuss with a health care provider to determine if you should receive the vaccine.
  • People who are sick with a high fever or serious infection worse than a cold should wait until they feel better.
  • Anyone who has had an allergic or severe reaction to a previous dose of any vaccine (talk to your health care provider).
  • Any component in a vaccine may be a potential allergen. The most common allergens for Men-C-C vaccines are:
    • Menjugate®: diphtheria CRM-197 toxoid carrier protein and latex
    • NeisVac-C®: tetanus toxoid carrier protein
  • For more information on contents of vaccine refer to the Canadian Immunization Guide, Evergreen Edition

Don’t forget to update your record of protection

After you or your child receives a vaccine, update your immunization record (yellow card). For children in school or child care, please call the Health Department to update your child’s immunization record. Keep immunization records in a safe place!

*Parents must contact the Health Department if you object to immunization based on conscious or religious beliefs, or if your child cannot be immunized for medical reasons.

September 20, 2017